Remove 2003 Remove Access Remove Digestion Remove Events
article thumbnail

AIMS v. Garland: A Disappointment for Psilocybin Advocates, but Progressive Policy May Still be on the Horizon

Cannabis Law Report

Congress passed the RTT Act in 2018 to give qualifying patients access to investigational drugs outside of a clinical trial setting. In response to the DEA’s letter, AIMS, Dr. Aggarwal, and two patients seeking access to psilocybin under the RTT Act filed a lawsuit in the U.S. Enter the Right to Try (RTT) Act. The RTT Act. DEA, 333 F.3d

DEA 52
article thumbnail

Here’s What Neuroimaging Can Tell Us About the Psychedelic Experience

SpeedWeed

You won’t get overwhelmed, in fact you’ll digest complex neuroimaging techniques with ease. This means scientists can witness the precise sequence of cognitive events as they occur in the brain instead of a nebulous cloud of brain activity. I’m not sure why that is, considering shrooms are by far the most accessible.

article thumbnail

The Immortality Key: Lost on The Road to Eleusis

SpeedWeed

As well, Carl Ruck, a mentor of sorts to Muraresku, championed for his pioneering worth in entheogenic scholarship throughout The Immortality Key , reviewed my own book dealing with the use of entheogens in the Bible, in 2003, in the London England Sunday Times. Was There a Whiff of Cannabis About Jesus? ” The Sunday Times, Jan.